EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Is There a Role for Muscle Relaxants in Migraine Management? A Narrative Review

Heba Banihani, Marta Waliszewska-Prosół, Christopher Robinson, Abdulrazaq S. Albilali, Jeannine Abrons, Kinga Gecse, Merve Kozak, Mario M. F. Peres, Sait Ashina

Headache and Pain Research · 31.10.2026 · 27 (3) · 186-192

DOI: 10.62087/hpr.2026.0025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Headache and Pain Research, erschienen am 31.10.2026. Verfasst von Heba Banihani und 8 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine is a debilitating neurological condition that affects approximately 15% of the global population and frequently co-occurs with musculoskeletal conditions that add to its burden. Neck pain affects 73%–90% of patients and often prompts off-label prescribing of muscle relaxants to relieve perceived muscular contributions to headache. This narrative review examines the clinical evidence, pharmacological profiles, and safety considerations for centrally acting antispasmodic and antispasticity agents (tizanidine, baclofen, cyclobenzaprine, and methocarbamol), peripherally acting agents (dantrolene), and other agents (carisoprodol and eperisone). Although limited data from landmark trials in the early 2000s suggest potential preventive benefits of tizanidine and baclofen, high-quality, contemporary evidence supporting the routine use of muscle relaxants for migraine is lacking in the broader literature. Their substantial adverse effects, including sedation, dizziness, and the risk of dependence, may further increase patient disability. This review supports current clinical guidelines that prioritize migraine-specific therapies and suggests reserving muscle relaxants for individual cases with prominent musculoskeletal symptoms. Further studies are needed to assess the efficacy and safety of their short- and long-term use in migraine management.

Zitieren

APA

Banihani, H., Waliszewska-Prosół, M., Robinson, C., Albilali, A. S., Abrons, J., Gecse, K., Kozak, M., Peres, M. M. F., & Ashina, S. (2026). Is There a Role for Muscle Relaxants in Migraine Management? A Narrative Review. Headache and Pain Research, 27(3), 186-192. https://doi.org/10.62087/hpr.2026.0025

Vancouver

Banihani H, Waliszewska-Prosół M, Robinson C, Albilali AS, Abrons J, Gecse K, et al. Is There a Role for Muscle Relaxants in Migraine Management? A Narrative Review. Headache and Pain Research. 2026;27(3):186-192. doi:10.62087/hpr.2026.0025

BibTeX
@article{Banihani2026,
  author = {Banihani, Heba and Waliszewska-Prosół, Marta and Robinson, Christopher and Albilali, Abdulrazaq S. and Abrons, Jeannine and Gecse, Kinga and Kozak, Merve and Peres, Mario M. F. and Ashina, Sait},
  title = {Is There a Role for Muscle Relaxants in Migraine Management? A Narrative Review},
  journal = {Headache and Pain Research},
  year = {2026},
  volume = {27},
  number = {3},
  pages = {186--192},
  doi = {10.62087/hpr.2026.0025}
}
Kostenlos starten →